Skip to main content

Prognostic Significance of the Karyotype in Patients with Primary Myelodysplastic Syndrome

  • Conference paper
Acute Leukemias II

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 33))

  • 152 Accesses

Abstract

The myelodysplastic syndrome (MDS) comprises a group of heterogeneous hematologic disorders characterized by ineffective hematopoiesis and a high risk of transformation to acute leukemia. Studies on the role of chromosomes in MDS are still controversial as contrasted with those in acute non-lymphocytic leukemia (ANLL), where specific translocations have been associated with certain morphologic types [1]. Only a few reports described cytogenetic findings in a significant number of patients with MDS [2–4]. The purpose of this study was to determine the frequency of chromosome anomalies in a large series of patients with primary MDS, their correlation with morphologic subtypes, and prognostic impact.

This study was supported by the Deutsche Forschungsgemeinschaft

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD (1983) The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia:a 12-year study (1970–1982). Cancer Genet Cytogenet 10:219–236

    Article  PubMed  CAS  Google Scholar 

  2. Second International Workshop on Chromosomes in Leukemia (1980) Chromosomes in preleukemia. Cancer Genet Cytogenet 2:108–113

    Article  Google Scholar 

  3. Knapp RH, Dewald GW, Pierre RV (1985) Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 60:507–516

    PubMed  CAS  Google Scholar 

  4. Nowell PC, Besa EC, Stelmach T, Finan JB (1986) Chromosome studies in preleukemic states:V. Prognostic significance of single versus multiple abnormalities. Cancer 58:2571–2575

    Article  PubMed  CAS  Google Scholar 

  5. Bennett JM, Catowsky D, Daniel MT, Flan- drin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of myelodysplastic syndromes. Br J Haematol 51:189–199

    PubMed  CAS  Google Scholar 

  6. Kardon N, Schulman P, Degnan TJ, Budman DR, Davis J, Vinciguerra V (1982) Cytogenetic findings in the dysmyelopoietic syndrome. Cancer 50:2834–2838

    Article  PubMed  CAS  Google Scholar 

  7. Ayraud N, Donzeau M, Raynand S, Lampert JC (1983) Cytogenetic study of 88 cases of refractory anemia. Cancer Genet Cytogenet 8:243–248

    Article  PubMed  CAS  Google Scholar 

  8. Gold EJ, Conjalka M, Pelus LM et al. (1983) Marrow cytogenetic and cell culture analysis of the myelodysplastic syndromes:insights into pathophysiology and prognosis. J Clin Oncol 1:627–634

    PubMed  CAS  Google Scholar 

  9. Borgstrom GH (1986) Cytogenetics of the myelodysplastic syndromes. Scand J Haematol 36 [Suppl 45]:74–77

    Article  Google Scholar 

  10. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765–1772

    PubMed  CAS  Google Scholar 

  11. Heim S, Mitelman F (1986) Chromosome abnormalities in the myelodysplastic syndromes. Clin Haematol 15:1003–1021

    PubMed  CAS  Google Scholar 

  12. Horiike S, Taniwaki M, Misawa S, Abe T (1988) Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 62 (6):1129

    Article  PubMed  CAS  Google Scholar 

  13. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67:1721–1730

    PubMed  CAS  Google Scholar 

  14. Le Beau MM, Albain KS, Larson RA (1986) Clinical and cytogenetic correlation in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia:further evidence of characteristic abnormalities of chromosomes no 5 and 7. J Clin Oncol 4:325–345

    PubMed  Google Scholar 

  15. Anderson RT, Bagby GC Jr (1982) The prognostic value of chromosome studies in patients with preleukemic syndrome (hemopoietic dysplasia). Leuk Res 6:175–181

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Suciu, S., Weh, H.J., Hossfeld, D.K. (1990). Prognostic Significance of the Karyotype in Patients with Primary Myelodysplastic Syndrome. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74643-7_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50984-4

  • Online ISBN: 978-3-642-74643-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics